Opportunity Map (COM)
• Proteomics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Proteomics Market, By Regions
• Proteomics Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Proteomics Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Proteomics Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Proteomics Market Forecast including Production, Consumption, Import and Export Forecast by
Type, Applications and Region.
• Research Findings and Conclusion
Global Proteomics Market: Regional Analysis
On the basis of region, the global proteomics market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to account for the largest market share in the proteomics market
over the forecast period. The market growth is attributed to increasing collaboration and
partnership activities by key players in this region. For instance, in November 2018, Thermo
Fisher Scientific Inc. and Symphogen entered into a two-year collaborative partnership to
deliver validated platform workflows for simplified characterization and quality monitoring of
complex therapeutic proteins. Under this agreement, Symphogen would have access to Thermo
Fisher’s Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC-MS/MS)
system with BioPharma Option for creating, testing, and validating the platform workflows for
intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures. Moreover,
Symphogen will focus on the development of automated multi-attribute method (MAM)
workflows for monitoring critical quality attributes of proteins using high-resolution accurate-
mass mass spectrometry in a quality control environment.